[The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
Acute hepatitis for intravenous amiodarone is an uncommon problem with scarce appearances in medical literature. Sometimes, it has postulated that the vehicle of the intravenous preparation and not the active principle is the possible cause of this complication. We report a patient with fulminating hepatitis and severe encephalopathy following the administration of intravenous amiodarone. We present also the clinical evolution of the patient after reintroduction of oral amiodarone. In the end, we make a review of the associated literature with our case.
López-Gómez
D
D
Servicio de Cardiología, Ciudad Sanitaria, L'Hospitalet de Llobregat, Barcelona.
Nicolás
J
J
Frigola
J M
JM
Manito
N
N
Esplugas
E
E
D000208:Acute Disease; D000284:Administration, Oral; D000638:Amiodarone / Q000008:administration & dosage* / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D002908:Chronic Disease; D016027:Heart Transplantation; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D017180:Tachycardia, Ventricular / Q000150:complications / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone